Several studies in mouse models for neurodegenerative diseases demonstrated opposing roles of TREM2 deficiency on Aβ and tau pathologies (two pathological hallmarks of AD) with amelioration of amyloid and exacerbation of tau pathology (33). This evidence concerns the gene MAPT and amyloidosis.